Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis

BACKGROUND: Direct-acting antivirals (DAAs) are known to improve tolerability and have higher efficacy and shorter treatment durations compared with conventional interferon (IFN)-based treatments for hepatitis C virus (HCV) infection. Management of drug interactions and maintenance of patient adhere...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Haruna, Ikesue, Hiroaki, Ikemura, Mai, Miura, Rieko, Fujita, Kazumi, Chung, Hobyung, Suginoshita, Yoshiki, Inokuma, Tetsuro, Hashida, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048910/
https://www.ncbi.nlm.nih.gov/pubmed/30026959
http://dx.doi.org/10.1186/s40780-018-0113-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048910/
https://www.ncbi.nlm.nih.gov/pubmed/30026959
http://dx.doi.org/10.1186/s40780-018-0113-3

Ejemplares similares